These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9162475)

  • 61. Telomere shortening is associated with malformation in p53-deficient mice after irradiation during specific stages of development.
    Bekaert S; Derradji H; De Meyer T; Michaux A; Buset J; Neefs M; Mergeay M; Jacquet P; Van Oostveldt P; Baatout S
    DNA Repair (Amst); 2005 Aug; 4(9):1028-37. PubMed ID: 15990362
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The p53 family orchestrates the regulation of metabolism: physiological regulation and implications for cancer therapy.
    Napoli M; Flores ER
    Br J Cancer; 2017 Jan; 116(2):149-155. PubMed ID: 27884017
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Overexpression of p53 and long-term survival in colon carcinoma.
    Auvinen A; Isola J; Visakorpi T; Koivula T; Virtanen S; Hakama M
    Br J Cancer; 1994 Aug; 70(2):293-6. PubMed ID: 8054278
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Tumor-suppressor p53: implications for tumor development and prognosis.
    Kirsch DG; Kastan MB
    J Clin Oncol; 1998 Sep; 16(9):3158-68. PubMed ID: 9738588
    [TBL] [Abstract][Full Text] [Related]  

  • 65. VHL and p53: tumor suppressors team up to prevent cancer.
    Semenza GL
    Mol Cell; 2006 May; 22(4):437-9. PubMed ID: 16713574
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Hematopoietic insults damage bone marrow niche by activating p53 in vascular endothelial cells.
    Si S; Nakajima-Takagi Y; Iga T; Tsuji M; Hou L; Oshima M; Koide S; Saraya A; Yamazaki S; Takubo K; Kubota Y; Minamino T; Iwama A
    Exp Hematol; 2018 Jul; 63():41-51.e1. PubMed ID: 29709619
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A conformation hypothesis for the suppressor and promoter functions of p53 in cell growth control and in cancer.
    Milner J
    Proc Biol Sci; 1991 Aug; 245(1313):139-45. PubMed ID: 1682937
    [TBL] [Abstract][Full Text] [Related]  

  • 68. JunB can substitute for Jun in mouse development and cell proliferation.
    Passegué E; Jochum W; Behrens A; Ricci R; Wagner EF
    Nat Genet; 2002 Feb; 30(2):158-66. PubMed ID: 11818961
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Function of the p53 gene: choice between life and death.
    Chumakov PM
    Biochemistry (Mosc); 2000 Jan; 65(1):28-40. PubMed ID: 10702638
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Problems of radiobiology and p53 protein].
    Mazurik VK; Moroz BB
    Radiats Biol Radioecol; 2001; 41(5):548-72. PubMed ID: 11721349
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Codon 104 of p53 is not an adaptively selected site for extreme environments in mammals of the Tibet plateau.
    Liu Z
    Proc Natl Acad Sci U S A; 2014 Jun; 111(23):E2357. PubMed ID: 24872448
    [No Abstract]   [Full Text] [Related]  

  • 72. Reply to Liu: Amino acid 104 asparagine/glutamic acid of p53 is an adaptively selected site for extreme environments in mammals of the Tibet plateau.
    Zhao Y; Ren JL; Wang MY; Zhang ST; Liu Y; Li M; Cao YB; Zu HY; Chen XC; Wu CI; Nevo E; Chen XQ; Du JZ
    Proc Natl Acad Sci U S A; 2014 Jun; 111(23):E2358. PubMed ID: 25061640
    [No Abstract]   [Full Text] [Related]  

  • 73. Development: the natural history of genes.
    Scott MP
    Cell; 2000 Jan; 100(1):27-40. PubMed ID: 10647929
    [No Abstract]   [Full Text] [Related]  

  • 74. Attempt at quantitative analysis of interindividual variability in stress response of leucocyte levels in mice from the viewpoint of control theory.
    Vácha J; Kacer O
    Biophysik; 1970; 6(4):280-9. PubMed ID: 5425861
    [No Abstract]   [Full Text] [Related]  

  • 75. 'Patching' embryonic development to cancer.
    Dickman S
    Ann Oncol; 1997 Mar; 8(3):209-10. PubMed ID: 9137783
    [No Abstract]   [Full Text] [Related]  

  • 76. Neuronal IL-17 controls
    Godthi A; Min S; Das S; Cruz-Corchado J; Deonarine A; Misel-Wuchter K; Issuree PD; Prahlad V
    Proc Natl Acad Sci U S A; 2024 Mar; 121(12):e2315248121. PubMed ID: 38483995
    [TBL] [Abstract][Full Text] [Related]  

  • 77. p53 Disruption Increases Uracil Accumulation in DNA of Murine Embryonic Fibroblasts and Leads to Folic Acid-Nonresponsive Neural Tube Defects in Mice.
    Lachenauer ER; Stabler SP; Field MS; Stover PJ
    J Nutr; 2020 Jul; 150(7):1705-1712. PubMed ID: 32271909
    [TBL] [Abstract][Full Text] [Related]  

  • 78. p53: updates on mechanisms, biology and therapy (I).
    Lane DP; Verma CS
    J Mol Cell Biol; 2019 Mar; 11(3):185-186. PubMed ID: 31222355
    [No Abstract]   [Full Text] [Related]  

  • 79. Design and synthesis of anticancer 1-hydroxynaphthalene-2-carboxanilides with a p53 independent mechanism of action.
    Spaczyńska E; Mrozek-Wilczkiewicz A; Malarz K; Kos J; Gonec T; Oravec M; Gawecki R; Bak A; Dohanosova J; Kapustikova I; Liptaj T; Jampilek J; Musiol R
    Sci Rep; 2019 Apr; 9(1):6387. PubMed ID: 31011161
    [TBL] [Abstract][Full Text] [Related]  

  • 80. An amino acid-based oral rehydration solution (AA-ORS) enhanced intestinal epithelial proliferation in mice exposed to radiation.
    Yin L; Gupta R; Vaught L; Grosche A; Okunieff P; Vidyasagar S
    Sci Rep; 2016 Nov; 6():37220. PubMed ID: 27876791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.